Skip to main content

Encorafenib User Reviews & Ratings

Brand names: Braftovi

Encorafenib has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.

  • Manu
  • Taken for 1 to 6 months
  • September 30, 2020

Braftovi (encorafenib) for Colorectal Cancer "Para nada le servicio a mi esposa se puso peor y murio"

1 / 10
Was this helpful?YesNo
1 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.